What is the differential diagnosis and first‑line treatment for a bilateral foot rash in an adult with no additional history?

Bilateral Foot Rash: Differential Diagnosis and First-Line Treatment

For a bilateral foot rash in an adult, tinea pedis (athlete's foot) is the most common diagnosis, and first-line treatment is topical terbinafine 1% cream applied once daily for 1 week, which achieves approximately 94% mycological cure rates. 1

Immediate Life-Threatening Exclusions

Before proceeding with routine management, rule out Rocky Mountain Spotted Fever (RMSF) if the patient has ANY of the following: fever, headache, myalgias, or recent tick exposure/outdoor activity in endemic areas during April-September. 2, 3

• RMSF can begin on the ankles and wrists as small (1-5 mm) blanching pink macules 2-4 days after fever onset, progressing to maculopapular lesions with central petechiae that spread to palms and soles. 2, 3
• Critical action: If systemic symptoms are present, initiate doxycycline 100 mg orally twice daily immediately without waiting for laboratory confirmation, as the case-fatality rate is 5-10% with half of deaths occurring within 9 days. 2, 3
• Key pitfall: Up to 20% of RMSF patients never develop a rash, and fewer than 50% have a rash in the first 3 days; absence of rash does not exclude the diagnosis. 2, 3

Most Likely Diagnosis: Tinea Pedis

Clinical presentation includes fine scaly or vesiculopustular eruption that is often itchy, with fissures and scaling between toes, commonly affecting all areas of the foot. 1

Three Main Clinical Forms:

• Interdigital type: Most common, affects toe web spaces with maceration and scaling 4, 5
• Hyperkeratotic (moccasin-type): Diffuse scaling and hyperkeratosis of plantar surface 4, 5
• Vesiculobullous (inflammatory): Vesicles and bullae, typically on instep or mid-foot 4, 5

Risk Factors to Assess:

• Male gender (more common than females) 1
• Obesity and diabetes 1
• Athletes (swimmers, runners—up to 22% prevalence) 1
• Warm, humid environments 1

Causative Organisms:

• Trichophyton rubrum (most common) 1, 4
• Trichophyton mentagrophytes 1, 4
• Epidermophyton floccosum 1, 4

Diagnostic Approach

KOH wet-mount examination of skin scrapings from the active border of the lesion is recommended as point-of-care testing; clinical diagnosis alone has low accuracy. 4

• Fungal culture or molecular tools can confirm diagnosis if needed 4
• Important: The accuracy of clinical diagnosis without microscopy is poor, so consider KOH preparation when feasible 4

First-Line Treatment Algorithm

For Localized/Superficial Disease:

Topical terbinafine 1% cream once daily for 1 week is the preferred first-line treatment, with mycological cure rates of approximately 94%. 1

Alternative topical options (if terbinafine unavailable):

• Ciclopirox olamine 0.77% cream or gel applied twice daily for 4 weeks achieves ~60% cure at end of treatment and 85% two weeks post-treatment 1
• Clotrimazole 1% cream twice daily for 4 weeks 1
• Other options: ketoconazole, butenafine, tolnaftate, amorolfine 4

For Severe, Extensive, or Failed Topical Therapy:

Oral terbinafine 250 mg once daily for 1 week has similar efficacy to 4 weeks of topical clotrimazole but with faster clinical resolution. 1

Reserve oral therapy for:

• Severe or extensive disease 4
• Failed topical antifungal therapy 4
• Concomitant onychomycosis 4
• Immunocompromised patients 4

Alternative oral agents:

• Itraconazole 100 mg once daily for 2 weeks (similar efficacy to terbinafine but slightly higher relapse rate) 1
• Fluconazole (dosing varies) 4

Important Safety Considerations:

Terbinafine adverse events include occasional isolated neutropenia and rare liver failure (typically in patients with preexisting liver disease). 1

Key Differential Diagnoses to Consider

Contact Dermatitis (Irritant or Allergic):

• Often from footwear materials, soaps, or topical products 6
• Treatment: Hydrocortisone 2.5% applied 3-4 times daily 6
• Patch testing can distinguish allergic from irritant type 6

Atopic Eczema:

• Predominantly affects flexural areas, associated with personal/family history of atopy 3
• Less well-demarcated borders than contact dermatitis 3

Bacterial Infection (Microbial Eczema):

• Affects medial interdigital spaces and dorsal areas of medial toes 7
• Spreads to dorsum of foot rather than plantar surface (unlike tinea pedis) 7
• Staphylococcus aureus and/or hemolytic streptococci cultured 7
• Requires antibacterial treatment in addition to anti-inflammatory therapy 7

Psoriasis:

• Well-demarcated erythematous plaques with silvery scale 3
• Often symmetric, involving extensor surfaces 3

Prevention Strategies

Foot powder after bathing has been associated with decline in tinea pedis rates from 8.5% to 2.1% over 3.5 years, primarily reducing T. mentagrophytes. 1

Additional preventive measures:

• Careful and thorough drying between toes after showers 1
• Daily changes of socks 1
• Periodic cleaning of athletic footwear 1
• Avoid walking barefoot in communal areas 4

Critical Pitfalls to Avoid

• Do not assume tinea pedis based on appearance alone—KOH examination significantly improves diagnostic accuracy 4
• Do not miss bacterial superinfection—look for purulent drainage, increased warmth, or lymphangitic streaking suggesting cellulitis 1, 5
• Do not overlook diabetes or immunosuppression—these patients require more aggressive treatment and have higher risk of complications 1, 5
• Do not forget to treat underlying conditions such as interdigital maceration, venous eczema, or trauma that predispose to infection 1
• Do not dismiss systemic symptoms—fever with foot rash requires immediate consideration of RMSF and empiric doxycycline 2, 3

Expected Clinical Course

With appropriate antifungal treatment, prognosis is good and lesions should resolve within 1-6 weeks depending on severity and treatment modality. 4

Untreated lesions may persist, progress, and serve as a portal for bacterial invasion leading to recurrent cellulitis. 1, 5

Relapse rates are significant (33% in some studies), requiring patient education on preventive measures. 7